Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Outlook Therapeutics FY21 EPS $(0.35) Up From $(0.67) YoY

Outlook Therapeutics (NASDAQ:OTLK) reported quarterly losses of $(0.35) per share. This is a 47.76 percent increase over losses of $(0.67) per share from the same period last year.
byBenzinga Newsdesk
December 22, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Outlook Therapeutics (NASDAQ:OTLK) reported quarterly losses of $(0.35) per share. This is a 47.76 percent increase over losses of $(0.67) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0